Optometrists in Mason, MI Accepting Medicare
7 Optometrists found. Showing 1 - 7
 Dr. Glen A. Linsley Optometrist, Pc Optometrist Medicare: Medicare Enrolled Practice Location: 109 E Maple St, Mason, MI 48854 Phone: 517-676-4499 Fax: 517-676-3221 |
 Dr. Holly Dow Swartz, OD Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1103 S Cedar St, Mason, MI 48854 Phone: 517-676-9350 Fax: 517-676-8040 |
 Dr. Richard J. Sims, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 1103 S Cedar St, Mason, MI 48854 Phone: 517-676-9350 Fax: 517-676-8040 |
Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 1103 S Cedar St, Mason, MI 48854 Phone: 517-676-9350 Fax: 517-676-8040 |
Dr. Chad Elston Linsley, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 109 E Maple St, Mason, MI 48854 Phone: 517-676-4499 |
Dr. Glen A Linsley, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 109 E Maple St, Mason, MI 48854 Phone: 517-676-4499 Fax: 517-676-3221 |
Bennett Optometry Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 3181 Sandhill Rd, Mason, MI 48854 Phone: 636-200-4393 |
News Archive
New theory challenges orthodox view that cancer develops in each host by mutational accidents
A new way to look at cancer - by tracing its deep evolutionary roots to the dawn of multicellularity more than a billion years ago - has been proposed by Paul Davies of Arizona State University's Beyond Center for Fundamental Concepts in Science in collaboration with Charles Lineweaver of the Australian National University.
Proscia introduces new concept to transform pathology labs, drive digital evolution
Proscia Inc., a software solutions provider for digital pathology, announced today the introduction of its new concept: Software as a Lab. Proscia's President and CEO David West will outline how the pathology lab of the future will operate in a session at the 2017 Digital Pathology Congress: USA on July 10-11 in Chicago.
ACT initiates enrollment in TEMPASURE cardiac ablation catheter CE Mark clinical trial
Advanced Cardiac Therapeutics, Inc., a developer of innovative temperature-sensing cardiac ablation systems, today announced that the first patients have been enrolled in a first-in-man CE Mark clinical trial of the safety and performance of the company's TEMPASURE™ cardiac ablation catheter. The TEMPASURE system is the world's first RF cardiac ablation catheter to offer both saline irrigation and temperature-sensing technology.
Wake Forest Baptist conducts $24 million project to accelerate development of new therapies
Whether it's the Ebola virus or Sarin and Ricin, a key to responding to chemical or biological attacks is having effective antidotes at the ready. To accelerate the development of new therapies, Wake Forest Baptist Medical Center's Institute for Regenerative Medicine is leading a unique $24 million federally funded project to develop a "body on a chip" that will be used to develop these countermeasures.
› Verified 5 days ago
Occupational Therapists
Speech-Language Pathologists
Physical Therapists
Chiropractors
Optometrists